1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China;
2. The Second Hospital of Shanxi Medical University, Taiyuan, China;
3. LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
4. Clinical Pathology Department of Karolinska Hospital, Karolinska Institute, Solna, Sweden